Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 15 studies | 28% ± 7% | |
| mesothelial cell | 7 studies | 47% ± 19% | |
| retinal ganglion cell | 4 studies | 64% ± 20% | |
| amacrine cell | 4 studies | 49% ± 17% | |
| interneuron | 4 studies | 30% ± 14% | |
| GABAergic amacrine cell | 3 studies | 21% ± 6% | |
| GABAergic neuron | 3 studies | 23% ± 5% |
Insufficient scRNA-seq data for expression of CALB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 80% | 3279.62 | 369 / 459 | 76% | 29.05 | 851 / 1118 |
| brain | 88% | 4242.10 | 2328 / 2642 | 67% | 15.06 | 472 / 705 |
| adrenal gland | 99% | 2334.54 | 255 / 258 | 44% | 46.38 | 101 / 230 |
| ovary | 45% | 707.90 | 81 / 180 | 59% | 12.17 | 253 / 430 |
| intestine | 62% | 655.14 | 598 / 966 | 37% | 7.15 | 195 / 527 |
| adipose | 98% | 5326.03 | 1183 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 2.20 | 1 / 328 | 80% | 26.94 | 143 / 178 |
| esophagus | 18% | 141.46 | 265 / 1445 | 41% | 11.10 | 75 / 183 |
| lung | 9% | 144.08 | 54 / 578 | 42% | 17.79 | 486 / 1155 |
| uterus | 2% | 24.37 | 3 / 170 | 45% | 13.41 | 206 / 459 |
| bladder | 5% | 27.05 | 1 / 21 | 38% | 10.39 | 191 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 6.39 | 15 / 45 |
| skin | 17% | 122.05 | 311 / 1809 | 15% | 2.53 | 73 / 472 |
| stomach | 2% | 14.81 | 6 / 359 | 31% | 5.70 | 88 / 286 |
| thymus | 0% | 2.65 | 3 / 653 | 15% | 1.84 | 92 / 605 |
| heart | 14% | 155.06 | 123 / 861 | 0% | 0 | 0 / 0 |
| kidney | 1% | 9.70 | 1 / 89 | 12% | 0.82 | 105 / 901 |
| eye | 0% | 0 | 0 / 0 | 9% | 2.38 | 7 / 80 |
| blood vessel | 7% | 118.71 | 100 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 7% | 2.72 | 30 / 406 |
| prostate | 0% | 1.54 | 1 / 245 | 1% | 0.09 | 7 / 502 |
| peripheral blood | 1% | 21.72 | 13 / 929 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.38 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1900271 | Biological process | regulation of long-term synaptic potentiation |
| GO_0099509 | Biological process | regulation of presynaptic cytosolic calcium ion concentration |
| GO_0043195 | Cellular component | terminal bouton |
| GO_0005634 | Cellular component | nucleus |
| GO_0005829 | Cellular component | cytosol |
| GO_0030425 | Cellular component | dendrite |
| GO_0045202 | Cellular component | synapse |
| GO_0098688 | Cellular component | parallel fiber to Purkinje cell synapse |
| GO_0005921 | Cellular component | gap junction |
| GO_0099534 | Molecular function | calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | CALB2 |
| Protein name | Calretinin (CR) (29 kDa calbindin) Calbindin 2 (Calretinin) |
| Synonyms | CAB29 hCG_2011413 |
| Description | FUNCTION: Calretinin is a calcium-binding protein which is abundant in auditory neurons. |
| Accessions | ENST00000635371.2 ENST00000562305.5 ENST00000634959.1 ENST00000302628.9 ENST00000635154.1 A6NER6 ENST00000635576.1 P22676 H3BN14 ENST00000349553.9 ENST00000490520.1 H3BMN5 |
